The corporate selected is having status as dissolved (liquidated) hence financial data is not available. You may check its last filed documents by making a request.
About
Basic Data Updated:
4 months agoIndustry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U73100UP2009PTC037333 |
Company No. | 037333 |
Company Classification | Private Limited Indian Non-Government Company |
Incorporation Date | 11 May 2009 |
Date of AGM | 20 Sep 2018 |
Date of Balance Sheet | 31 Mar 2018 |
Listing Status | Unlisted |
ROC Code | Roc Kanpur |
Financials of Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 0.03% increase. The company also saw a slight improvement in profitability, with a 8.39% increase in profit. The company's net worth moved up by a moderate rise of 6.02%.
Corporate Structure
Unlock access to Vanthys Pharmaceutical Development's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Vanthys Pharmaceutical Development Private Limited
Unlock and access historical data on people associated with Vanthys Pharmaceutical Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
ST
Shwetank Tiwari Company SecretaryAppointment Date: 16-Jan-2018
Status: Current
NG
Nitin Garg CFOAppointment Date: 06-Feb-2017
Status: Current
Board Members(3)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vanthys Pharmaceutical Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanthys Pharmaceutical Development's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Recent activity within the organization
Director Appointment
Saravanakumar Dhakshinamoorthy was appointed as a Additional Director was appointed as a Additional Director on 15 May 2019 & has been associated with this company since 5 years 4 months .
15 May 2019Annual General Meeting
Vanthys Pharmaceutical Development Private Limited last Annual general meeting of members was held on 20 Sep 2018 as per latest MCA records.
20 Sep 2018Director Appointment
Shyamsundar Bang was appointed as a Director was appointed as a Director on 20 Sep 2018 & has been associated with this company since 5 years 11 months .
20 Sep 2018Balance Sheet
Vanthys Pharmaceutical Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kanpur.
31 Mar 2018Director Appointment
Benny Thomas was appointed as a Director was appointed as a Director on 28 Mar 2018 & has been associated with this company since 6 years 5 months .
28 Mar 2018
Recent News, Updates & Announcement
- Jubilant Pharmova to Divest Entire Stake in Sofie Bio.
Chemindigest 03 Feb 2024
- Jubilant Life celebrates ANDA approval for Itraconazole Capsules thanks BSE for the update.
When you finally get that ANDA approval for Itraconazole Capsules and youre feeling like a boss Thanks BSE for the update JubilantLife ANDAAchievement FeelingBlessed.
Moneycontrol 27 Feb 2017
- Jubilant gets USFDA nod for generic antifungal capsules.
Business Line 27 Feb 2017
- Jubilant Life Sciences trades high on the bourses.
Finalaya 08 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Vanthys Pharmaceutical Development Private Limited?